BUENA, N.J., Nov. 9 /PRNewswire-FirstCall/ -- IGI, INC. IG is scheduled to report financial results for the third quarter 2004 on Friday, November 12, 2004, prior to the market open.
IGI will hold a conference call at 9:00 AM ET on Friday, November 12, 2004 to discuss its financial results and continuing business plans. Interested parties are invited to listen to the call live over the Internet at http://www.companyboardroom.com or by dialing 1-800-591-6923, passcode 67117042. International participants should call 1-617-614-4907 using the same passcode as above. For interested parties unable to join the call, a replay will be available until, November 19, 2004, by dialing 1-888-286-8010, passcode 71086168.
IGI is applying its patented Novasome(R) microencapsulation technologies to deliver pharmaceuticals, dermaceuticals, cosmetics, skin care, nutrients and other industrial products. Novasomes(R) drive large molecules deep into the skin in a moisturizing non-irritating delayed release cream
This report contains forward-looking statements relating to IGI's hopes and expectations for the future. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward- looking statements. Without limiting the foregoing, words such as "will", "possible," "one time," "provides an opportunity," "continue" and similar expressions are intended to identify forward-looking statements. Such statements involve a number of risks and uncertainties and actual future events and results could differ materially from those indicated by such forward-looking statements due to general economic conditions, and the risk factors detailed in IGI's periodic reports and registration statements filed with the Securities and Exchange Commission.
© 2004 PRNewswire